Weei/nesn Jimmy Fund Radio-telethon

Arbella Insurance Vice President Gayle O'Connell brings a BIG donation check for the Jimmy Fund Radio Telethon.

Laurie H. Glimcher, MD, was named President and CEO of Dana-Farber CancerInstitute in 2016. She is also Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. Dr. Glimcher is a distinguished immunologist, widely renowned for her work in one of the most promising areas of cancer research. A trailblazer in cancer research, Dr. Glimcher's research identified keytranscriptional regulators of protective immunity and the origin of pathophysiologicimmune responses underlying autoimmune, infectious, and malignant diseases. Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to medical literature. Aside from her research efforts, Dr. Glimcher has been a s

In early 2020, it became difficult for Clinton to eat. It was during the pandemicand much harder at the time to see a doctor, so it took a while before he was able to get checked out. In January 2021, Clinton was diagnosed with esophageal cancer that metastasized into his lungs. His treatment included six months on a feeding tube, chemotherapy and radiationtreatments. In summer 2021, he received an esophagectomy and now comes in forchemotherapy every other week. He will continue these sessions for the foreseeablefuture. The American Cancer Society estimates that there will be about 22,370 newesophageal cancer cases diagnosed (17,690 in men and 4,680 in women) in 2024. Esophageal cancer is more common among men than among women. Thelifetime risk of esophageal cancer in the United States is about 1 in 127 in men andabout 1 in 434 in women.

Red Sox legend and Hall of Famer Carlton Fisk talks about the long-time support he has given to the Jimmy Fund and how Fenway has changed since his playing days.

Dr. Hartley-Brown's clinical area of focus is treating patients with MultipleMyeloma. This is an incurable blood cancer, that affects African Americans moreprevalently than other ethnic populations. She also practices clinical research, mainly in the relapsed refractory myeloma disease setting. Dr. Hartley-Brown actively participates as a principal investigator in clinical trials within the Alliance for Clinical Trials, investigator-initiated and investigator sponsored trials. Her area of interest in clinical trials includes use of immunotherapies and targeted therapies, such asbispecific/tri-specific antibodies, antibody-drug conjugates and modern immunemodulating drugs (ex. cereblon modulators).

Jaimey was diagnosed with prostate cancer in 2008. He was treated and received a clean bill of health and remained cancer-free. In May 2015, a routine blood donation led to a life-changing discovery when the Red Cross director urged him to seek immediate medical attention. Jaimey was diagnosed with chronic lymphocytic leukemia (CLL), which, contrary to its typical slow progression, advanced rapidly in his case. Jaimey remained active, cycling and running to maintain his mental well-being.However, six to nine months ago, his CLL numbers began to rise again, promptingdiscussions about future treatments. Although his white blood cell count is high and he has low antibodies, making illnesses particularly severe, Jaimey remains optimistic with Dana-Farber's support. After obtaining an A.B. cum laude in chemistry at Harvard College, Dr. Davidscompleted his M.D. cum laude at Yale University School of Medicine. He served as an intern, resident, and assistant chief resident in internal medicine at NewYork-Presbyterian

Erica Howes is joined by patient Sophia and her daughter Alice to share that Howes will be making a big donation to the Jimmy Fund.

Brock Holt nicknamed, “The Brock Star” is a former Major League Baseball utilityplayer who played for the Boston Red Sox (2013–2019). He served as the Jimmy Fund Captain from 2015-2019 and has been a long-time supporter of Dana-Farber’s fundraising efforts. After serving as Jimmy Fund Captain, Holt and Lakyn have remained steadfastsupporters of Dana-Farber and the Jimmy Fund. They ran the Boston Marathon ®for the Dana-Farber Cancer Institute Marathon Challenge in 2023, sold t-shirts to raise funds for the Jimmy Fund Clinic, where pediatric patients receive care, and have participated in many Jimmy Fund Clinic patient events, virtually and in person, always focused on promoting the work at Dana-Farber. Melany Duval is the Senior Vice President and Chief Philanthropy Officer atDana-Farber Cancer Institute and responsible for the fundraising strategy and tactics in the Division of Philanthropy; including The Dana-Farber Campaign. Duval is a seasoned development executive with over three decades of experience in

Matt Waning's cancer journey began in 2021, at the age of 34, when he wasdiagnosed with testicular cancer. The aggressive nature of his illness led to surgery that removed a tumor the size of a watermelon, along with his left testicle and kidney, as the tumor had reached his aorta. Following surgery, he underwent two months of preventive chemotherapy known as VIP treatment and celebrated being in remission by August 2021. However, the VIP treatment came with a rare side effect—a potential risk of developing acute myeloid leukemia (AML). Unfortunately, in January 2023, Matt was diagnosed with AML as a result of the chemotherapy he had previously received. Matt is an avid Boston sports fan, with a particular passion for the Bruins. Musicis another love of his, offering solace and joy throughout his journey. As the oldest of three siblings, he shares a special bond with his family, including his dog Mogley, named after the main character from "The Jungle Book." Dr. Stone is currently the Director of the Adult Ac

Dr. Cutler received his MD from McGill University, Montreal, Canada. Hesubsequently received his MPH from the Harvard school of Public Health. He completed postgraduate training in Internal Medicine at Royal Victoria Hospital, Montreal, followed by a fellowship in Hematology/Oncology at DFCI. In 2002, he joined DFCI, where he currently is a member of the Hematologic Malignancies staff. Dr. Cutler is a Director of the Adult Cell Transplantation Program, Director of ClinicalResearch for Stem Cell Transplantation and Director of the Stem Cell TransplantationSurvivorship Program. He also works as an Associate Professor of Medicine at Harvard Medical School.

Eva had unexplained fevers for about a week. She was pale and sleeping a lot. Herparents took her to the pediatrician, who advised them to take Eva immediately to theemergency room. Her bloodwork revealed she had acute lymphoblastic leukemia (ALL). After two years of treatment including chemotherapy, she was finally in remission,but cancer returned just two weeks later. Eva needed a stem cell transplant and her twin brother, Joey, was a perfect match for the procedure. She received a stem cell transplant from Joey in 2022. She also has received CAR-Tcell therapy, a type of immunotherapy. She received her cells in May and continues to be seen twice weekly to track her progress with therapy and platelet infusions. Acute lymphoblastic leukemia is aggressive and progresses quickly. It affects thelymphoid-cell-producing stem cells, in particular a type of white blood cell called Tlymphocytes as opposed to acute lymphocytic leukemia (ALL) which commonly affects B lymphocytes. ALL is the most common type of childhoo

“It was nothing to worry about,” Andrew was repeatedly told, when he visitedurgent care twice for pain in his pelvis area. But the discomfort wouldn’t go away, so he met with his primary care physician who referred him to a urologist for an ultrasound. The scans led to a testicular cancer diagnosis in early 2023. It was caught early enough, and he was told there was a good prognosis. The cancer had only spread very lightly to his lymph nodes. Adam works as the director of data analytics for a pharmaceutical company. Heloves vacationing with his family, watching his children play their sports (soccer for his son Jacob and gymnastics for his daughter Julia) and caring for his 2004 BMW. He hopes to help normalize conversations around testicular cancer for other men so they can overcome stigmas and shame around it. Today, he and his wife Kara arecelebrating their wedding anniversary. Dr. Atish Choudhury is a medical oncologist and clinical/translational investigatorwithin the Lank Center for Genitourinary Oncolog

Red Sox reliever Liam Hendriks joins to share his personal battle with stage 4 non-Hodgkin's lymphoma, getting involved with the Jimmy Fund, and working back from injury to hopefully help the team as they push for the playoffs.

During the summer before her senior year in Boston College’s nursing program,Zoe started having chronic headaches, which were brushed off as anxiety andmigraines. Eventually, her left arm went numb, so doctors thought she could beexperiencing a focal seizure: a seizure that affects only one side of the brain. An MRI led to a brain tumor diagnosis. After surgery in 2017, she was declared cancer-free. Zoe worked at an infusion clinic in Waltham for two years prior to joiningDana-Farber—Chestnut Hill in 2021. After transferring her own healthcare toDana-Farber, however, she learned there is no cure for her cancer. Zoe was enrolled in the Indigo clinical trial and expects to continue taking an oral drug for the remainder of her life to prevent the brain tumor from returning. Zoe, who is currently pursuing her master’s degree in healthcare administration,says she often forms emotional bonds with patients and shares her story when it is appropriate and helpful. She’s training and fundraising for the Berlin Marathon

Tina was 33 when she was diagnosed with breast cancer. She discovered a bumpnear her clavicle and went to her OGBYN who promptly sent her for a mammogram.Tina is among a growing number of young women being diagnosed with breast cancer. Tina’s treatment started with six rounds of chemotherapy, followed by a double mastectomy earlier this summer. She is currently doing some rounds of low dosage chemotherapy throughout the rest of this year and recently started radiation treatment as well. Tina works as a Government Relations Manager and works in public policy forDoorDash. Tina loves to travel and goes to Ireland several times a year. Tina and herfiancé Erik also spend a lot of time on outdoor adventures with their dog, Buddy. Dr. Mayer received her medical degree from Harvard Medical School, completed aresidency in Internal Medicine at Brigham and Women's Hospital, and a fellowship inHematology/Oncology at Dana-Farber Cancer Institute. She obtained a Master's inPublic Health from the Harvard School of Public He

Dr. Hahn is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. He serves as an Executive Vice President and the Chief Operating Officer at the Dana-Farber Cancer Institute. Dr. Hahn has made numerous discoveries that have informed our currentmolecular understanding of cancer. His laboratory has pioneered the use of integrated functional genomic approaches to identify and validate cancer targets. The tools, models and approaches that his laboratory has developed are widely used worldwide to discover and validate molecularly targeted cancer therapies. Dr. Hahn has served as the President of the American Society for ClinicalInvestigation and has been elected to the Association of American Physicians and the National Academy of Medicine. Dr. Hahn has been the recipient of many honors and awards including the Wilson S. Stone Award from M.D. Anderson Cancer Cen

Red Sox relievers Chris Martin and Kenley Jansen join the show to talk about their second year as part of the Jimmy Fund and the impact they've seen while being a part of it. The pitchers also react to a walk-off win on the previous night and how ready the team is to make a push for the playoffs in the final month and a half of the regular season.

Dr. James Fanale worked in healthcare for nearly five decades, but never reallyknew what it meant to be a patient until he was told he had cancer - Stage 4 lungcancer. James was president and CEO of Care New England, retiring in 2022, shortly after being diagnosed. Jim typically ran the Falmouth Road Race and insists on being able to continuerunning. Since his cancer diagnosis, Jim has focused on his personal life. He’s retired and planning trips with his wife, Deb. Jim is in the middle of writing a book called “Onward,” which focuses on the empathy in medicine and the emotional weight of the journey of patients and their caregivers. All the proceeds will be donated to a new “caregivers fund” at the Dana-Farber. Dr. Barbie is the Director of the Lowe Center for Thoracic Oncology atDana-Farber Cancer Institute and an Associate Professor of Medicine at HarvardMedical School. He is also Associate Director of the Belfer Center for Applied CancerScience and an Associate Member of the Broad Institute. According to

Denise Beady was 37 years old when she was diagnosed with early-stage breastcancer in 2017. She sought out care at Dana-Farber, in part because she was soyoung at the time of her diagnosis. In 2022, Denise felt another lump under her arm, and after tests and scans, it was revealed that Denise was having a recurrence of her breast cancer and it returned as stage 4 Denise works as a paramedic and dispatcher. When she’s not working, she enjoysspending time with her husband Robert, and her two boys Tyler, 14, and Ryan, 11. She spends a lot of time driving them to different sports activities. Both of her kids do obstacle training at a gym in Weymouth. Her oldest runs cross country and her younger son plays soccer. Dr. Burstein is one of the world’s leading experts in the multi-disciplinary and medical management of early- and late-stage breast cancer. Dr. Burstein has led or participated in innumerable clinical trials for breast cancer, including Phase 1, 2 and 3 studies of novel agents, biological treatments, che

Jillian McFall joins Gresh and Fauria to discuss her battle with pancreatic cancer. Dr. Brian Wolpin joins to further discuss Jillian's journey.  Jillian landed in the ICU and cancer unit in Boston; where she met Dr. Brian Wolpin, who explained that she’d need to start chemotherapy as soon as possible or she’d die. She was so sick and doesn’t even remember her first chemotherapy session. Today, the tumor has been reduced to half its original size. She’s now on a break from her job and credits her family and endocrinology team for their unwavering support. Dr. Brian Wolpin received his medical degree from Harvard Medical School in 2001. He later completed his Internal Medicine residency at Brigham and Women's Hospital and his Medical Oncology fellowship at the Dana-Farber Cancer Institute. He is the director of the Gastrointestinal Cancer Center and serves as the Robert T. and Judith B. Hale Chair in Pancreatic Cancer. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies,